ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript July 29, 2025

ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.03623 EPS, expectations were $-0.02.

Operator: Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies Fourth Quarter and Fiscal Year-end 2025 Earnings Call. We appreciate your time and interest in IPA. Today’s call will be led by our CEO, Dr. Jennifer Bath; and Interim CFO, Joe...